Schubert & Co’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-50
Closed -$1.29K 1350
2023
Q1
$1.29K Buy
50
+8
+19% +$214 ﹤0.01% 1093
2022
Q4
$993 Sell
42
-10
-19% -$270 ﹤0.01% 1181
2022
Q3
$1K Buy
52
+15
+41% +$526 ﹤0.01% 1260
2022
Q2
$1K Buy
37
+32
+640% +$1.36K ﹤0.01% 1306
2022
Q1
$0 Buy
5
+2
+67% +$144 ﹤0.01% 1328
2021
Q4
$0 Buy
+3
New +$359 ﹤0.01% 1280

Other funds holding TDOC

Schubert & Co's TDOC Position: Q2 2023 in Review

Schubert & Co sold out of Teladoc Health (TDOC) in Q2 2023, closing a stake of 50 shares — an estimated $1.29K sold.

Schubert & Co first reported a position in TDOC in Q4 2021 and held it in 6 quarters. The position peaked at $1.29K in Q1 2023. 431 funds tracked by Wall St. Rank hold TDOC as of Q2 2023.

  • Schubert & Co reported no remaining Teladoc Health position as of Q2 2023 after selling out during the quarter.
  • Schubert & Co sold 50 Teladoc Health shares in Q2 2023, an estimated $1.29K.
  • Schubert & Co first reported a position in Teladoc Health in Q4 2021 and held it in 6 quarters.
  • Schubert & Co's Teladoc Health position peaked at $1.29K in Q1 2023.
  • 431 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2023.

Based on Schubert & Co's 13F filing for Q2 2023, filed 4 Aug 2023.